Versatile Protein Coronation Approach with Multiple Depleted Serum for Creating Biocompatible, Precision Nanomedicine.

Au nanospheres drug delivery dysopsonin protein corona surface functionalization

Journal

Small (Weinheim an der Bergstrasse, Germany)
ISSN: 1613-6829
Titre abrégé: Small
Pays: Germany
ID NLM: 101235338

Informations de publication

Date de publication:
07 2022
Historique:
revised: 19 05 2022
received: 30 03 2022
pubmed: 2 7 2022
medline: 29 7 2022
entrez: 1 7 2022
Statut: ppublish

Résumé

The protein corona effect has long been treated as the evil source behind delivery efficacy issues. In this study, this concept is challenged by showcasing that the protein corona can serve as a versatile functionalization approach to improve the delivery efficacy or mitigate nanocytotoxicity. To this end, the depleted serum is introduced to create nanomaterials carrying functionally distinct protein corona, referred to as PCylated nanomaterials. It is confirmed that the passivation with depleted serum helps reduce the toxicity and pro-inflammatory response. Furthermore, the same method can be leveraged to enhance the capacity of nanomaterials to undergo endocytosis as well as their potential as an agonist for the NF-κB pathways. The comparable stability of protein corona created by late and early-stage serum reveals that the chanceless interaction with nanomaterials, rather than an inadequate binding strength, may be behind the failure of enriching certain components. The PCylation strategy is extended to cancer patient-derived fluid, creating a set of T1 and T3-stage cancer-specific nanotherapeutics to retard the metastasis of cancer cells, while leaving normal endothelial negligibly affected. It is hoped the novel PCylation approach validated here can shed light on the future development of precision nanomedicine with improved delivery efficacy.

Identifiants

pubmed: 35775952
doi: 10.1002/smll.202202002
doi:

Substances chimiques

Protein Corona 0
Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2202002

Informations de copyright

© 2022 Wiley-VCH GmbH.

Références

S. Wilhelm, A. J. Tavares, D. Qin, S. Ohta, W. C. Chan, Nat. Rev. Mater. 2016, 1, 16014.
T. Cedervall, I. Lynch, S. Lindman, T. Berggard, E. Thulin, H. Nilsson, K. A. Dawson, S. Linse, Proc. Natl. Acad. Sci. USA 2007, 104, 2050.
E. Casals, T. Pfaller, A. Duschl, G. J. Oostingh, V. Puntes, ACS Nano 2010, 4, 3623.
I. Lynch, A. Salvati, K. A. Dawson, Nat. Nanotechnol. 2009, 4, 546.
A. Salvati, A. S. Pitek, M. P. Monopoli, K. Prapainop, F. B. Bombelli, D. R. Hristov, P. M. Kelly, C. Åberg, E. Mahon, K. A. Dawson, Nat. Nanotechnol. 2013, 8, 137.
N. Bertrand, P. Grenier, M. Mahmoudi, E. M. Lima, E. A. Appel, F. Dormont, J. M. Lim, R. Karnik, R. Langer, O. C. Farokhzad, Nat. Commun. 2017, 8, 777.
B. D. Johnston, W. G. Kreyling, C. Pfeiffer, M. Schäffler, H. Sarioglu, S. Ristig, S. Hirn, N. Haberl, S. Thalhammer, S. M. Hauck, Adv. Funct. Mater. 2017, 27, 1701956.
S. Schöttler, G. Becker, S. Winzen, T. Steinbach, K. Mohr, K. Landfester, V. Mailänder, F. R. Wurm, Nat. Nanotechnol. 2016, 11, 372.
M. Wang, O. J. Gustafsson, G. Siddiqui, I. Javed, H. G. Kelly, T. Blin, H. Yin, S. J. Kent, D. J. Creek, K. Kempe, Nanoscale 2018, 10, 10863.
D. Rosenblum, N. Joshi, W. Tao, J. M. Karp, D. Peer, Nat. Commun. 2018, 9, 1410.
E. Papini, R. Tavano, F. Mancin, Front. Immunol. 2020, 11, 567365.
X. Lu, P. Xu, H. M. Ding, Y. S. Yu, D. Huo, Y. Q. Ma, Nat. Commun. 2019, 10, 4520.
I. Alberg, S. Kramer, M. Schinnerer, Q. Hu, R. Zentel, Small 2020, 16, 1907574.
G. Caracciolo, S. Palchetti, V. Colapicchioni, L. Digiacomo, D. Pozzi, A. L. Capriotti, G. La Barbera, A. Laganà, Langmuir 2015, 31, 10764.
F. Giulimondi, E. Vulpis, L. Digiacomo, M. V. Giuli, A. Mancusi, A. L. Capriotti, A. Laganà, A. Cerrato, R. Z. Chiozzi, C. Nicoletti, ACS Nano 2022, 16, 2088.
Y. Zheng, X. Zhong, Z. Li, Y. Xia, Part. Part. Syst. Charact. 2014, 31, 266.
D. Liu, W. Wu, J. Ling, S. Wen, N. Gu, X. Zhang, Adv. Funct. Mater. 2011, 21, 1498.
J. Lee, J. H. Huh, K. Kim, S. Lee, Adv. Funct. Mater. 2018, 28, 1707309.
A. Gessner, A. Lieske, B. R. Paulke, R. H. Müller, Eur. J. Pharm. Biopharm. 2002, 54, 165.
C. D. Walkey, J. B. Olsen, H. Guo, A. Emili, W. C. Chan, J. Am. Chem. Soc. 2012, 134, 2139.
L. Vroman, A. Adams, G. Fischer, P. Munoz, Blood 1980, 55, 156.
Z. Lyu, F. Zhou, Q. Liu, H. Xue, Q. Yu, H. Chen, Adv. Funct. Mater. 2016, 26, 5787.
X. Jiang, S. Weise, M. Hafner, C. Röcker, F. Zhang, W. J. Parak, G. U. Nienhaus, J. R. Soc. Interface 2010, 7, S5.
L. K. Müller, J. Simon, C. Rosenauer, V. Mailänder, S. Morsbach, K. Landfester, Biomacromolecules 2018, 19, 374.
V. H. Nguyen, B.-J. Lee, Int. J. Nanomed. 2017, 12, 3137.
C. Auffray, M. H. Sieweke, F. Geissmann, Annu. Rev. Immunol. 2009, 27, 669.
P. J. Murray, T. A. Wynn, Nat. Rev. Immunol. 2011, 11, 723.
M. A. Dobrovolskaia, S. E. Mcneil, Nat. Nanotechnol. 2007, 2, 469.
D. Zhang, L. Wei, M. Zhong, L. Xiao, H. W. Li, J. Wang, Chem. Sci. 2018, 9, 5260.
Z. Tu, K. Achazi, A. Schulz, R. Mülhaupt, S. Thierbach, E. Rühl, M. Adeli, R. Haag, Adv. Funct. Mater. 2017, 27, 1701837.
P. Khanna, C. Ong, B. H. Bay, G. H. Baeg, Nanomaterials 2015, 5, 1163.
P. J. Murray, J. E. Allen, S. K. Biswas, E. A. Fisher, D. W. Gilroy, S. Goerdt, S. Gordon, J. A. Hamilton, L. B. Ivashkiv, T. Lawrence, Immunity 2014, 41, 14.
S. Behzadi, V. Serpooshan, W. Tao, M. A. Hamaly, M. Y. Alkawareek, E. C. Dreaden, D. Brown, A. M. Alkilany, O. C. Farokhzad, M. Mahmoudi, Chem. Soc. Rev. 2017, 46, 4218.
C. H. Lai, C. Y. Lin, H. T. Wu, H. S. Chan, Y. J. Chuang, C. T. Chen, C. C. Lin, Adv. Funct. Mater. 2010, 20, 3948.
F. Charbgoo, M. Nejabat, K. Abnous, F. Soltani, S. M. Taghdisi, M. Alibolandi, W. T. Shier, T. W. Steele, M. J. Ramezani, J. Controlled Release 2018, 272, 39.
M. Almeida, E. Susnik, B. Drasler, P. Taladriz-Blanco, B. Rothen-Rutishauser, Chem. Soc. Rev. 2021, 50, 5397.
S. Sigismund, L. Lanzetti, G. Scita, P. P. Di Fiore, Nat. Rev. Mol. Cell Biol. 2021, 22, 625.
S. D. Tito, J. Hervás, A. Vliet, S. A. Tooze, Trends Biochem. Sci. 2020, 45, 484.
A. K. Varkouhi, M. Scholte, G. Storm, H. J. Haisma, J. Controlled Release 2011, 151, 220.
B. Rathore, K. Sunwoo, P. Jangili, J. Kim, J. H. Kim, M. Huang, J. Xiong, A. Sharma, Z. Yang, J. Qu, Biomaterials 2019, 211, 25.
I. Khan, P. S. Steeg, Brit. J. Cancer 2020, 124, 66.
M. Qin, J. Zhang, M. Li, D. Yang, D. Liu, S. Song, J. Fu, H. Zhang, W. Dai, X. Wang, Theranostics 2020, 10, 1213.
K. I. Cupic, J. J. Rennick, A. P. Johnston, G. K. Such, Nanomedicine 2019, 14, 215.
C. Almeida, M. D. Amaral, Cell. Mol. Life Sci. 2020, 77, 4729.
B. Kornmann, K. Weis, Science 2020, 367, 507.
G. Eelen, P. de Zeeuw, M. Simons, P. Carmeliet, Circ. Res. 2015, 116, 1231.
M. I. Setyawati, C. Y. Tay, D. Docter, R. H. Stauber, D. T. Leong, Chem. Soc. Rev. 2015, 44, 8174.
D. Du, N. Chang, S. Sun, M. Li, H. Yu, J. Controlled Release 2014, 182, 99.
G. Bazzoni, E. Dejana, Physiol. Rev. 2004, 84, 869.
P. Fang, R. Jinsong, Q. Xiaogang, Chem. Soc. Rev. 2018, 47, 404.
M. Munir, S. Hussain, R. Anwar, M. Waqas, J. Ali, Sci. Inquiry Rev. 2020, 4, 14.
L. F. Chen, W. C. Greene, Nat. Rev. Mol. Cell Biol. 2004, 5, 392.
P. Kinaret, G. Scala, A. Federico, J. Sund, D. Greco, Small 2020, 16, 1907609.
M. R. Zinatizadeh, B. Schock, G. M. Chalbatani, P. K. Zarandi, S. A. Jalali, S. R. Miri, Genes Dis. 2021, 8, 287.
S. Srijampa, S. Buddhisa, S. Ngernpimai, C. Leelayuwat, P. Tippayawat, Bioconjug. Chem. 2020, 31, 1133.
J. Ren, R. Cai, J. Wang, M. Daniyal, C. Chen, Nano Lett. 2019, 19, 4692.
A. Decout, J. D. Katz, S. Venkatraman, A. Ablasser, Nat. Rev. Immunol. 2021, 21, 548.
K. P. Hopfner, V. Hornung, Nat. Rev. Mol. Cell Biol. 2020, 21, 501.
B. Guey, A. Ablasser, Curr. Opin. Immunol. 2022, 74, 164.
Q. Zhou, Y. Zhou, T. Li, Z. Ge, Macromol. Biosci. 2021, 21, 2100133.
R. L. Siegel, K. D. Miller, A. G. Sauer, S. A. Fedewa, L. F. Butterly, J. C. Anderson, A. Cercek, R. A. Smith, A. Jemal, Ca-Cancer J. Clin. 2020, 70, 145.
X. Guan, H. H. Yin, X. H. Xu, G. Xu, Y. Zhang, B. G. Zhou, W. W. Yue, C. Liu, L. P. Sun, H. X. Xu, Adv. Funct. Mater. 2020, 30, 2000326.
R. V. Ghartavol, R. Mombeiny, A. Salmaninejad, S. M. R. Sorkhabadi, M. R. Jaafari, H. Mirzaei, J. Cell Physiol. 2018, 233, 9223.
C. C. Han, F. S. Wan, J. Breast Cancer 2018, 21, 354.
R. M. Visalakshan, L. E. González García, M. R. Benzigar, A. Ghazaryan, J. Simon, A. Mierczynska-Vasilev, T. D. Michl, A. Vinu, V. Mailänder, S. Morsbach, K. Landfester, K. Vasilev, Small 2020, 16, 2000285.
S. Abbina, L. E. Takeuchi, P. Anilkumar, K. Yu, J. C. Rogalski, R. A. Shenoi, I. Constantinescu, J. N. Kizhakkedathu, Nat. Commun. 2020, 11, 3048.
K. E. Wheeler, A. J. Chetwynd, K. M. Fahy, B. S. Hong, J. A. Tochihuitl, L. A. Foster, I. Lynch, Nat. Nanotechnol. 2021, 16, 617.
I. Alberg, S. Kramer, M. Schinnerer, Q. Hu, C. Seidl, C. Leps, N. Drude, D. Möckel, C. Rijcken, T. Lammers, M. Diken, M. Maskos, S. Morsbach, K. Landfester, S. Tenzer, M. Barz, R. Zentel, Small 2020, 16, 1907574.
E. Heideveld, M. Horcas-Lopez, M. Lopez-Yrigoyen, L. M. Forrester, J. W. Pollard, Method Enzymol. 2019, 632, 113.
H. Mohammad-Beigi, Y. Hayashi, C. M. Zeuthen, H. Eskandari, D. S. Sutherland, Nat. Commun. 2020, 11, 4535.

Auteurs

Chan Wang (C)

Department of Medicinal Chemistry, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, P. R. China.

Mengdie Xue (M)

Department of Medicinal Chemistry, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, P. R. China.

Xiao Liu (X)

Department of Medicinal Chemistry, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, P. R. China.

Jingjing Chen (J)

Department of Medicinal Chemistry, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, P. R. China.

Mengdie Jiang (M)

Department of Medicinal Chemistry, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, P. R. China.

Liuting Zheng (L)

Department of Medicinal Chemistry, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, P. R. China.

Ruxuan Ma (R)

Department of Medicinal Chemistry, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, P. R. China.

Chengjin Ding (C)

Department of Medicinal Chemistry, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, P. R. China.

Yaping Tao (Y)

The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, No. 321, Zhongshan Road, Nanjing, 210008, P. R. China.

Hao Zhang (H)

Department of Oncology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, P. R. China.

Qin Liu (Q)

The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, No. 321, Zhongshan Road, Nanjing, 210008, P. R. China.
The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, No. 321, Zhongshan Road, Nanjing, 210008, P. R. China.

Da Huo (D)

Department of Medicinal Chemistry, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, P. R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH